Drug Database · Clinicians

Chlorpheniramine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine

Also known as: guaiphenesin (former British name, for guaifenesin) · acetaminophen (US name, for paracetamol)

Brands (3) Ac-Nex Forte, Codexin-DM, DexofenShow all

This entry appears to be Chlorphenamine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine registered under a variant spelling.

See the main Chlorphenamine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine monograph (kidney dosing, prescribing information, all brands) →

Analgesic/Antipyretic/Expectorant/Decongestant/Antitussive/Antihistamine; Analgesic/Antipyretic/Expectorant/Decongestant/Anti tussive/Antihistamine PH FDA category
Fixed-dose combination.

Controlled precursorRx · Prescription drugOTC · Over-the-counter3 PH products

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Over-the-counter (OTC) · Prescription (Rx) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Capsule: 250 mg/100 mg/25 mg/10 mg/1 mg, 325 mg/50 mg/10 mg/10 mg/2 mg

Registered products in the Philippines

3 products registered with the Food and Drug Administration (FDA) Philippines list Chlorpheniramine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products3
Philippine FDA-registered products for Chlorpheniramine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine
Package insert
Ac-Nex ForteParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorpheniramine Maleate
250 mg/100 mg/25 mg/10 mg/1 mg CapsuleAlu/PE Foil Strip x 10's (Box of 100's); Alu/PE Foil Strip x 1's as Physician's Sample
Rx
La Croesus Pharma, Inc.Philippines
Trader: Medical and Pharmaceutical Specialties, Inc.
DR-XY42713
Sep 30, 2028
Codexin-DMParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorpheniramine Maleate
250 mg/100 mg/25 mg/10 mg/1 mg CapsuleAlu/PE Foil Strip x 10's (Box of 100's)
OTC
La Croesus Phara, Inc.Philippines
Trader: Medical and Pharmaceutical Specialties, Inc.
DRP-17496
Jan 14, 2031
DexofenParacetamol + Guaifenesin + Phenylpropanolamine (as hydrochloride) + Dextromethorphan hydrobromide + Chlorpheniramine maleate
325 mg/50 mg/10 mg/10 mg/2 mg CapsuleAlu/Alu Stripped Foil x 10's (Box of 100's)
OTC
Drugmaker's Laboratories, Inc.Philippines
Trader: CHMI Pharma, Inc.
DR-XY48824
Jul 31, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .